HYDERABAD: The World Health Organisation (WHO) will be taking a final call on Bharat Biotech’s Emergency Use. Also Listing (EUL) application for India’s first indigenously developed Covid-19 vaccine Covaxin next week-. The global health body said on Tuesday evening.
“They scheduled WHO & an independent group of experts to meet next week to carry out the risk/benefit assessment and come to a final decision whether to grant Emergency Use Listing to Covaxin,” WHO tweeted after a meeting of its Strategic Advisory Group of Experts (SAGE) to discuss the Covaxin EUL application.
Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis & submitted additional information
— World Health Organization (WHO) (@WHO)
“Covaxin manufacturer, Bharat Biotech, has been submitting data to WHO on a rolling basis. They submitted additional info at WHO’s request on 27 September. WHO experts are currently reviewing this info & if it addresses all questions raised. Also WHO assessment will be finalized next week,” WHO said.
WHO also pointed out that the EUL process carried out by WHO. They centered a technical advisory group of independent experts on determining if a manufactured product, like a vaccine, quality-assured, safe, and effective.
On September 29, WHO had updated the decision date for Covaxin EUL to October 2021 in its latest EUL guidance document for Covid-19 vaccines.
Image Credit: Wikipedia
Stay tuned with Artifex.News for further updates. Stay Connected, Stay Informed!